Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: A meta-analysis

Breast Cancer Research and Treatment

Volumn 122, Issue 1, 2010, Pages 251-257

  Yu, Ke Da ^a   Chen, Ao Xiang ^a   Yang, Chen ^a   Qiu, Li Xin ^a   Fan, Lei ^a   Xu, Wen Huan ^a   Shao, Zhi Ming ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Breast cancer; COX 2; Meta analysis; Polymorphism; Susceptibility

Indexed keywords

CYCLOOXYGENASE 2; PTGS2 PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; ETHNICITY; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; PENETRANCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; BIOLOGICAL MODEL; BREAST NEOPLASMS; CASE CONTROL STUDY; COHORT ANALYSIS; ETHNIC GROUP; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; META ANALYSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK; STATISTICS AND NUMERICAL DATA;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; CYCLOOXYGENASE 2; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MODELS, GENETIC; ODDS RATIO; PENETRANCE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK;

EID: 77953543706     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0688-3     Document Type: Article

References (28)

1. PD Pharoah AC Antoniou DF Easton BA Ponder 2008 Polygenes, risk prediction, and targeted prevention of breast cancer N Engl J Med 358 2796 2803 10.1056/NEJMsa0708739 1:CAS:528:DC%2BD1cXnvFamt7Y%3D 18579814 (Pubitemid 351930854)
2. DF Easton RA Eeles 2008 Genome-wide association studies in cancer Hum Mol Genet 17 R109 R115 10.1093/hmg/ddn287 1:CAS:528:DC%2BD1cXhtlyjsrbE 18852198
3. W Zheng J Long YT Gao C Li Y Zheng YB Xiang W Wen S Levy SL Deming JL Haines K Gu AM Fair Q Cai W Lu XO Shu 2009 Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1 Nat Genet 41 324 328 10.1038/ng.318 1:CAS:528:DC%2BD1MXhvFKjtbo%3D 19219042
4. LM Dong JD Potter E White CM Ulrich LR Cardon U Peters 2008 Genetic susceptibility to cancer: the role of polymorphisms in candidate genes JAMA 299 2423 2436 10.1001/jama.299.20.2423 1:CAS:528:DC%2BD1cXmsFGitL4%3D 18505952 (Pubitemid 351749241)
5. M Romano J Claria 2003 Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy FASEB J 17 1986 1995 10.1096/fj.03-0053rev 1:CAS:528: DC%2BD3sXovFOmtrg%3D 14597668 (Pubitemid 37392443)
6. JA Baron RS Sandler 2000 Nonsteroidal anti-inflammatory drugs and cancer prevention Annu Rev Med 51 511 523 10.1146/annurev.med.51.1.511 1:CAS:528:DC%2BD3cXisVelt7o%3D 10774479 (Pubitemid 30216052)
7. PG Moorman JM Grubber RC Millikan B Newman 2003 Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast Cancer Causes Control 14 915 922 10.1023/B:CACO.0000007973.59863.66 14750530 (Pubitemid 38091212)
8. PG Moorman J Sesay V Nwosu JG Kane AR de Cotret K Worley R Millikan 2005 Cyclooxygenase 2 polymorphism (Val511Ala), nonsteroidal anti-inflammatory drug use and breast cancer in African American women Cancer Epidemiol Biomark Prev 14 3013 3014 10.1158/1055-9965.EPI-05-0291 1:CAS:528:DC%2BD2MXhtlahs7jL (Pubitemid 43068842)
9. E Half XM Tang K Gwyn A Sahin K Wathen FA Sinicrope 2002 Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ Cancer Res 62 1676 1681 1:CAS:528:DC%2BD38XisVSisb4%3D 11912139
10. SC Wang HC Lien W Xia IF Chen HW Lo Z Wang M Ali-Seyed DF Lee G Bartholomeusz F Ou-Yang DK Giri MC Hung 2004 Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2 Cancer Cell 6 251 261 10.1016/j.ccr.2004.07.012 1:CAS:528:DC%2BD2cXot1Kis7k%3D 15380516 (Pubitemid 39222038)
11. K Subbaramaiah L Norton W Gerald AJ Dannenberg 2002 Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3 J Biol Chem 277 18649 18657 10.1074/jbc.M111415200 1:CAS:528:DC%2BD38XktFChs7s%3D 11901151 (Pubitemid 34952420)
12. LR Howe SH Chang KC Tolle R Dillon LJ Young RD Cardiff RA Newman P Yang HT Thaler WJ Muller C Hudis AM Brown T Hla K Subbaramaiah AJ Dannenberg 2005 HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice Cancer Res 65 10113 10119 10.1158/0008-5472.CAN- 05-1524 1:CAS:528:DC%2BD2MXhtFKkt7vO 16267038 (Pubitemid 41541494)
13. A Papafili MR Hill DJ Brull RJ McAnulty RP Marshall SE Humphries GJ Laurent 2002 Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response Arterioscler Thromb Vasc Biol 22 1631 1636 10.1161/01.ATV.0000030340.80207.C5 1:CAS:528:DC%2BD38XnsVKrtr8%3D 12377741
14. W Szczeklik M Sanak A Szczeklik 2004 Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma J Allergy Clin Immunol 114 248 253 10.1016/j.jaci.2004.05.030 1:CAS:528:DC%2BD2cXotVeis7s%3D 15316498 (Pubitemid 39119020)
15. X Zhang X Miao W Tan B Ning Z Liu Y Hong W Song Y Guo X Zhang Y Shen B Qiang FF Kadlubar D Lin 2005 Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer Gastroenterology 129 565 576 1:CAS:528:DC%2BD2MXpvVWmsbw%3D 16083713
16. W Zhu BB Wei X Shan P Liu 2009 -765G>C and 8473T>C polymorphisms of COX-2 and cancer risk: a meta-analysis based on 33 case-control studies Mol Biol Rep 10.1007/s11033-009-9685-1
17. U Langsenlehner B Yazdani-Biuki T Eder W Renner TC Wascher B Paulweber W Weitzer H Samonigg P Krippl 2006 The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk Clin Cancer Res 12 1392 1394 10.1158/1078-0432.CCR-05-2055 1:CAS:528:DC%2BD28XhsFalurk%3D 16489098 (Pubitemid 43342533)
18. U Vogel J Christensen BA Nexo H Wallin S Friis A Tjonneland 2007 Peroxisome proliferator-activated receptor-gamma2 Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes Carcinogenesis 28 427 434 10.1093/carcin/bgl170 1:CAS:528:DC%2BD2sXhs1Srs7o%3D 16959787 (Pubitemid 46321860)
19. JE Abraham P Harrington KE Driver J Tyrer DF Easton AM Dunning PD Pharoah 2009 Common polymorphisms in the prostaglandin pathway genes and their association with breast cancer susceptibility and survival Clin Cancer Res 15 2181 2191 10.1158/1078-0432.CCR-08-0716 1:CAS:528:DC%2BD1MXjtF2ru7Y%3D 19276290
20. LX Qiu B Chen C Mao P Zhan H Yuan K Xue J Li XC Hu 2009 STK15 F31I polymorphism is associated with breast cancer risk: a meta-analysis involving 25, 014 subjects Breast Cancer Res Treat 118 599 603 10.1007/s10549-009-0574-z 1:CAS:528:DC%2BD1MXhtlyls7%2FI
21. KD Yu GH Di L Fan J Wu Z Hu ZZ Shen W Huang ZM Shao 2009 A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer FASEB J 23 2274 2287 10.1096/fj.08-124073 1:CAS:528: DC%2BD1MXosVCns78%3D 19228880
22. DG Cox J Buring SE Hankinson DJ Hunter 2007 A polymorphism in the 3' untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study Breast Cancer Res 9 R3 10.1186/bcr1635 17214885 (Pubitemid 350215158)
23. L Gallicchio MA McSorley CJ Newschaffer LW Thuita HY Huang SC Hoffman KJ Helzlsouer 2006 Nonsteroidal antiinflammatory drugs, cyclooxygenase polymorphisms, and the risk of developing breast carcinoma among women with benign breast disease Cancer 106 1443 1452 10.1002/cncr.21763 1:CAS:528:DC%2BD28XjsFerurw%3D 16502408
24. J Gao Q Ke HX Ma Y Wang Y Zhou ZB Hu XJ Zhai XC Wang JW Qing WS Chen GF Jin JY Liu YF Tan XR Wang HB Shen 2007 Functional polymorphisms in the cyclooxygenase 2 (COX-2) gene and risk of breast cancer in a Chinese population J Toxicol Environ Health A 70 908 915 10.1080/15287390701289966 17479405 (Pubitemid 46699715)
25. S Kang YB Kim MH Kim KS Yoon JW Kim NH Park YS Song D Kang KY Yoo SB Kang HP Lee 2005 Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer Cancer Lett 217 11 16 10.1016/j.canlet.2004.06.053 1:CAS:528:DC%2BD2cXhtVKksbfN 15596291 (Pubitemid 39642861)
26. F Li GS Ren HY Li XY Wang L Chen J Li 2009 A novel single nucleotide polymorphism of the cyclooxygenase-2 gene associated with breast cancer Clin Oncol (R Coll Radiol) 21 302 305 1:STN:280:DC%2BD1M3jvVKltA%3D%3D
27. J Shen MD Gammon MB Terry SL Teitelbaum AI Neugut RM Santella 2006 Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk Breast Cancer Res 8 R71 10.1186/bcr1629 17181859 (Pubitemid 350201710)
28. LC Hartmann TA Sellers MH Frost WL Lingle AC Degnim K Ghosh RA Vierkant SD Maloney VS Pankratz DW Hillman VJ Suman J Johnson C Blake T Tlsty CM Vachon LJ Melton 3rd DW Visscher 2005 Benign breast disease and the risk of breast cancer N Engl J Med 353 229 237 10.1056/NEJMoa044383 1:CAS:528: DC%2BD2MXmt1KmsrY%3D 16034008 (Pubitemid 41058322)